Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies. - Wikidata - awgldk - TriplyDB

Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies.

Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies.

http://www.wikidata.org/entity/Q42163203

about

Calcium binding-mediated sustained release of minocycline from hydrophilic multilayer coatings targeting infection and inflammation Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics.Electrospun vancomycin-loaded coating on titanium implants for the prevention of implant-associated infections.Adhesion of Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa onto nanohydroxyapatite as a bone regeneration material.A Single B-repeat of Staphylococcus epidermidis accumulation-associated protein induces protective immune responses in an experimental biomaterial-associated infection mouse model Does presoaking synthetic mesh in antibiotic solution reduce mesh infections? An experimental study.Infection of orthopedic implants with emphasis on bacterial adhesion process and techniques used in studying bacterial-material interactions.Metal ion-assisted self-assembly of complexes for controlled and sustained release of minocycline for biomedical applications.Decreasing bacterial colonization of external fixation pins through nitric oxide release coatings.Controlled-release and local delivery of therapeutic antibodies.Effects of Fibronectin Coating on Bacterial and Osteoblast Progenitor Cells Adherence in a Co-culture Assay.A controlled antibiotic release system to prevent orthopedic-implant associated infections: An in vitro study.Effect of UV-photofunctionalization on oral bacterial attachment and biofilm formation to titanium implant material.Reduced bacterial adhesion to fibrinogen-coated substrates via nitric oxide release.Cefazolin embedded biodegradable polypeptide nanofilms promising for infection prevention: a preliminary study on cell responses.Nitric oxide-releasing S-nitrosothiol-modified xerogels.Development of a poly(ether urethane) system for the controlled release of two novel anti-biofilm agents based on gallium or zinc and its efficacy to prevent bacterial biofilm formation Improved antibacterial activity and biocompatibility on vancomycin-loaded TiO2 nanotubes: in vivo and in vitro studies.Inhibited bacterial biofilm formation and improved osteogenic activity on gentamicin-loaded titania nanotubes with various diameters Cubosomes and other potential ocular drug delivery vehicles for macromolecular therapeutics.Superhydrophobic materials for biomedical applications Osteogenic gene expression of canine bone marrow stromal cell and bacterial adhesion on titanium with different nanotubes.Layer-by-layer assembly of antibacterial coating on interbonded 3D fibrous scaffolds and its cytocompatibility assessment.Surface charge modification decreases Pseudomonas aeruginosa adherence in vitro and bacterial persistence in an in vivo implant model.Inhibition of bacterial adhesion and biofilm formation by dual functional textured and nitric oxide releasing surfaces.A multi-material coating containing chemically-modified apatites for combined enhanced bioactivity and reduced infection via a drop-on-demand micro-dispensing technique.Bio-Inspired Coating Strategies for the Immobilization of Polymyxins to Generate Contact-Killing Surfaces.Microparticle entrapment for drug release from porous-surfaced bone implants.Delivery of antibiotics from cementless titanium-alloy cubes may be a novel way to control postoperative infections.Inhibition of Staphylococcus epidermidis biofilm by trimethylsilane plasma coating Functional Coatings or Films for Hard-Tissue Applications Antibacterial burst-release from minimal Ag-containing plasma polymer coatings.Enhancing bioactivity of chitosan film for osteogenesis and wound healing by covalent immobilization of BMP-2 or FGF-2.Comparison of anti-bacterial prophylactic properties of two different vascular grafts: action of anti-bacterial graft coating and systemic antibiotic treatment.Drug loading and release of Tobramycin from hydroxyapatite coated fixation pins.Synthesis, characterization, antibacterial activity and cytotoxicity of hollow TiO2-coated CeO2 nanocontainers encapsulating silver nanoparticles for controlled silver release Integrating silver compounds and nanoparticles into ceria nanocontainers for antimicrobial applications

P2860

Q28538368-B6511872-1E55-430A-8CF9-0DA89A9AC9E6 Q30403958-5A0E2B89-8FCD-4355-981F-D8D42018AE36 Q33830334-894145C0-7E47-492E-8501-5ADBBD7786EE Q34226516-48B6AB70-6036-47CF-A5A8-CFD46CD75B79 Q34260797-991F75B1-456A-4D84-A9FA-0902B5EEC556 Q34501406-A04E4C8F-0C5D-4CF9-90B6-49F64D5AA38E Q34649528-4EA6D12C-3292-4D9E-8499-AF7D630CE883 Q35041149-4E8C1102-62FC-422B-8B6F-F6A57CDD6428 Q35053409-62C33611-0EE7-499C-A25A-CC11D64AF86A Q35842644-F04BFC92-B1D3-4A0B-BF4A-66F181F5E8A9 Q36068108-36598FC6-8470-4833-8E26-C2B8DA30B578 Q36280445-BF79F4E9-E292-402F-A75C-EF2090ACADC2 Q36341900-05ECE1B3-A4D4-4131-9736-088B85B21939 Q36970591-50A9E3EF-C194-47C4-BDA2-88A902504257 Q36977511-FFF74E2A-6F00-4C25-A16C-6187A72EC6C5 Q37345886-9CA8177A-5326-4E79-8B0E-AEC76DF7AAA0 Q37381385-CFD029CA-6B9A-401E-BD54-7E0A216636F4 Q37444022-550EA243-4B0C-4079-9746-DB6D1C80681A Q37635421-E256CBFD-FDBC-475B-B638-3B7D7C796EC5 Q38368715-5192A607-749A-41D8-BD54-814A4B79B805 Q38838607-BC3EAC9E-A4EB-42B9-8D88-BB7134E7EF44 Q39466838-E87F1E59-5C94-4775-9A17-883817E6764E Q39618090-A9912280-2F75-48F9-8A87-216ADF665719 Q40293607-E43BFF33-E3FB-44D6-AE55-AE745A3A5FD5 Q40372225-A0813CF3-7B25-4FAD-A5E4-05CA3EFF9D9D Q40439015-59B6F624-E4A9-475C-87C2-FA8139B48DD4 Q40636333-9684B0EF-8589-40E2-9EA7-109A9592297D Q41173391-86938095-BCDB-4E11-8CBA-A9CC1F7C1E2B Q41345133-484FA955-70B9-4200-9F3D-95893B9C0FFB Q41569871-BB5E0DED-A762-4F6E-9DCB-841738145899 Q41788441-AA7A4D39-A2F3-4780-9932-839A4A8A2F66 Q41856415-AFC1179C-7A85-49C5-8DAD-B1B1052F0CA1 Q42823469-2E029B51-A06C-489B-8AF8-C9B79FEC1F72 Q43098339-2BD2149F-8712-467B-9239-83270A466711 Q43795738-DCE44E95-5543-4C13-8C77-E1656669B4B8 Q58493078-C2CB18C5-F889-4199-905C-1394EFE272FB Q58493105-31278861-34A3-41C1-9E11-446DA0376FE8

P2860

Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies.

http://www.wikidata.org/entity/Q42163203

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Prophylactic treatment of gram ...... livered polyclonal antibodies.

@en

Prophylactic treatment of gram ...... livered polyclonal antibodies.

@nl

type

label

Prophylactic treatment of gram ...... livered polyclonal antibodies.

@en

Prophylactic treatment of gram ...... livered polyclonal antibodies.

@nl

prefLabel

Prophylactic treatment of gram ...... livered polyclonal antibodies.

@en

Prophylactic treatment of gram ...... livered polyclonal antibodies.

@nl

P1433

Q42163203-2A5B2DB2-5BA6-4CA3-81F7-8FC14FA1BBBF

P1476

Q42163203-F777D772-B5B9-429C-ABD1-23495E4670BA

P2093

Q42163203-04B04F5C-3558-4443-96B4-0D4F60EEB848

Q42163203-257845F0-61E2-4006-BA23-060821A237C7

Q42163203-46A4F138-24A6-4AF0-B530-2B652A3C82FC

Q42163203-5F5F8D73-C005-4130-91A0-CB6C991CDE1C

Q42163203-644992C2-1EB2-45C7-BA30-8EC388DF1D63

Q42163203-94B21428-FC92-4175-BA27-178962788DCF

P2860

Q42163203-02D69A7C-567E-450C-8769-A9A91F239C04

Q42163203-0A53960F-EB0D-47E2-877F-6B17B25CEDA4

Q42163203-14997303-BC6B-4965-9E91-B9A76C91816E

Q42163203-36A513FA-54DE-48F2-82EB-7772CD4D5E90

Q42163203-3D5673F5-86A6-4383-B24F-5CD0AE5E85AD

Q42163203-4331BCA3-90C5-466D-9BD0-7B5F0CDE46BD

Q42163203-43DA4DF2-B477-47ED-A4FA-C5232B2ED370

Q42163203-467E7B20-9574-4ED0-B1D7-91B128A368B9

Q42163203-51CB4470-3941-4F10-833B-08650027E38C

Q42163203-65E6C258-5A85-4F27-BA2C-98948DD1FE81

P304

Q42163203-9BCB5511-D31D-4D6A-A7D3-B357B4277F79

P31

Q42163203-020DD2F8-40E5-429F-BBCF-4E38B58A76F5

P356

Q42163203-D6BA17C0-1D43-4AA3-B22A-5AC28076B0A4

P433

Q42163203-72D957BD-33AF-49C8-8210-798B7957F819

P478

Q42163203-3DD2F305-FE49-48C1-A830-54DAF7478D01

P577

Q42163203-05A89278-37FA-41C2-8A2D-E7657A5F2DAC

P5875

Q42163203-F54F4E2B-D666-48F1-AE6D-0C0C09538F9C

P698

Q42163203-28A5C740-4B1E-4108-9F0D-6EF4928F7E73

P921

Q42163203-6B6A55FA-F9ED-45CE-895F-B1EA89EE9F1F

Q42163203-C5C9B353-CFE6-4C64-A071-B0883F3308FA

Q42163203-C613E543-D56D-4357-9811-A02FC92F5FC4

P356

P1433

Journal of Biomedical Materials Research Part B

P1476

Prophylactic treatment of gram ...... livered polyclonal antibodies.

@en

P2093

Adrian G Felts

http://www.w3.org/2001/XMLSchema#string

Andrea M Rediske

http://www.w3.org/2001/XMLSchema#string

David W Grainger

http://www.w3.org/2001/XMLSchema#string

Jeffrey B Slunt

http://www.w3.org/2001/XMLSchema#string

Kornelis A Poelstra

http://www.w3.org/2001/XMLSchema#string

Nazir A Barekzi

http://www.w3.org/2001/XMLSchema#string

P2860

Bacterial biofilms: a common cause of persistent infections

Staphylococcus aureus infections

Treatment of intra-abdominal infections with quinolones.

New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Antibody-based therapies for emerging infectious diseases.

Serum therapy revisited: animal models of infection and development of passive antibody therapy.

Return to the past: the case for antibody-based therapies in infectious diseases.

Pooled human immunoglobulins reduce adhesion of Pseudomonas aeruginosa in a parallel plate flow chamber.

Surgical irrigation with pooled human immunoglobulin G to reduce post-operative spinal implant infection.

The pandemic of antibiotic resistance.

P304

206-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBM.10069

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11525991

http://www.w3.org/2001/XMLSchema#string

P698

11835177

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

Gram-positive bacteria